换一批
换一批Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.
作者：
Boris,Julg [1]
;
Lynda,Dee [2]
;
Jintanat,Ananworanich [3]
;
Dan H,Barouch [4]
;
Katharine,Bar [5]
;
Marina,Caskey [6]
;
Donn J,Colby [7]
;
Liza,Dawson [8]
;
Krista L,Dong [9]
;
Karine,Dubé [10]
;
Joseph,Eron [11]
;
John,Frater [12]
;
Rajesh T,Gandhi [13]
;
Romas,Geleziunas [14]
;
Philip,Goulder [15]
;
George J,Hanna [16]
;
Richard,Jefferys [17]
;
Rowena,Johnston [18]
;
Daniel,Kuritzkes [19]
;
Jonathan Z,Li [19]
;
Udom,Likhitwonnawut [20]
;
Jan,van Lunzen [21]
;
Javier,Martinez-Picado [22]
;
Veronica,Miller [23]
;
Luis J,Montaner [24]
;
Douglas F,Nixon [25]
;
David,Palm [26]
;
Giuseppe,Pantaleo [27]
;
Holly,Peay [28]
;
Deborah,Persaud [29]
;
Jessica,Salzwedel [20]
;
Karl,Salzwedel [8]
;
Timothy,Schacker [30]
;
Virginia,Sheikh [31]
;
Ole S,Søgaard [32]
;
Serena,Spudich [33]
;
Kathryn,Stephenson [4]
;
Jeremy,Sugarman [34]
;
Jeff,Taylor [35]
;
Pablo,Tebas [36]
;
Caroline T,Tiemessen [37]
;
Randall,Tressler [8]
;
Carol D,Weiss [31]
;
Lu,Zheng [38]
;
Merlin L,Robb [3]
;
Nelson L,Michael [3]
;
John W,Mellors [39]
;
Steven G,Deeks [40]
;
Bruce D,Walker [41]
作者单位：
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA. Electronic address: bjulg@mgh.harvard.edu.
[1]
AIDS Action Baltimore, Baltimore, MD, USA.
[2]
US Military HIV Research Program, Henry Jackson Foundation, Bethesda, MD, USA.
[3]
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA.
[4]
Department of Medicine, University of Pennsylvania, Pennsylvania, PA, USA.
[5]
Laboratory of Molecular Immunology, Rockefeller University, New York, NY, USA.
[6]
Thai Red Cross AIDS Research Center, Bangkok, Thailand.
[7]
National Institute of Allergy and Infectious Diseases, Fishers ln Rockville, MD, USA.
[8]
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; University of KwaZulu Natal, Durban, South Africa.
[9]
Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
[10]
Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.
[11]
Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford National Institute of Health Research Biomedical Research Centre, Oxford, UK.
[12]
Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA.
[13]
Gilead Sciences, Foster City, CA, USA.
[14]
Department of Paediatrics, University of Oxford, Oxford, UK.
[15]
Merck, Kenilworth, NJ, USA.
[16]
Treatment Action Group, New York, NY, USA.
[17]
amfAR, New York, NY, USA.
[18]
Division of Infectious Diseases, Brigham and Women's Hospital, Cambridge, MA, USA.
[19]
AVAC: Global Advocacy for HIV Prevention, New York, NY, USA.
[20]
ViiV Healthcare, Brentford, UK.
[21]
AIDS Research Institute IrsiCaixa, Barcelona, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain; University of Vic-Central University of Catalonia, Barcelona, Spain.
[22]
Forum for Collaborative Research, Washington, DC, USA.
[23]
The Montaner Laboratory, The Wistar Institute, Philadelphia, PA, USA.
[24]
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York City, NY, USA.
[25]
Global HIV Prevention, and Treatment Clinical Trials Unit, University of North Carolina, Chapel Hill, NC, USA.
[26]
Service Immunology and Allergy, and Swiss Vaccine Research Institute, Centre Hospitalier Universitaire, Lausanne, Switzerland.
[27]
Research Triangle Institute, Research Triangle Park, NC, USA.
[28]
Pediatrics Infectious Disease, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
[29]
Division of Infectious Disease and International Medicine, University of Minnesota, Minneapolis, MN, USA.
[30]
Division of Antiviral Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
[31]
Department of Infectious Diseases, Aarhus University, Aarhus, Denmark.
[32]
Department of Neurology, Yale University, New Haven, CT, USA.
[33]
Berman Institute of Bioethics, University of North Carolina, Chapel Hill, NC, USA.
[34]
Collaboratory for AIDS Researchers for Eradication, University of North Carolina, Chapel Hill, NC, USA.
[35]
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
[36]
Cell Biology Research Laboratory, Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
[37]
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
[38]
Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
[39]
School of Medicine, University of California San Francisco, San Francisco, CA, USA.
[40]
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
[41]
主题词
抗逆转录病毒药(Anti-Retroviral Agents);HIV感染(HIV Infections);人类(Humans);病毒载量(Viral Load);停止治疗(Withholding Treatment)
DOI
10.1016/S2352-3018(19)30052-9
PMID
30885693
发布时间
2023-11-30
- 浏览38
The lancet. HIV
The lancet. HIV
2019年6卷4期
e259-e268页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
